Keeler Thomas Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,879
Closed -$621K 125
2025
Q1
$621K Sell
4,879
-4,100
-46% -$631K 0.3% 69
2024
Q4
$1.29M Buy
8,979
+3,662
+69% +$525K 0.46% 51
2024
Q3
$791K Buy
+5,317
New +$762K 0.25% 56
2023
Q4
Sell
-2,690
Closed -$428K 66
2023
Q3
$428K Buy
+2,690
New +$440K 0.16% 64

Other funds holding RGEN

Keeler Thomas Management's RGEN Position: Q2 2025 in Review

Keeler Thomas Management sold out of Repligen (RGEN) in Q2 2025, closing a stake of 4,879 shares — an estimated $621K sold.

Keeler Thomas Management first reported a position in RGEN in Q3 2023 and held it in 4 quarters. The position peaked at $1.29M in Q4 2024. 443 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Keeler Thomas Management reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • Keeler Thomas Management sold 4,879 Repligen shares in Q2 2025, an estimated $621K.
  • Keeler Thomas Management first reported a position in Repligen in Q3 2023 and held it in 4 quarters.
  • Keeler Thomas Management's Repligen position peaked at $1.29M in Q4 2024.
  • 443 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Keeler Thomas Management's 13F filing for Q2 2025, filed 31 Jul 2025.